• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

长链非编码 RNA PRRT3-AS1 沉默抑制前列腺癌细胞增殖并促进细胞凋亡和自噬。

Long non-coding RNA PRRT3-AS1 silencing inhibits prostate cancer cell proliferation and promotes apoptosis and autophagy.

机构信息

Department of Urology, China and Japan Union Hospital of Jilin University, Changchun, 130033, P.R. China.

出版信息

Exp Physiol. 2020 May;105(5):793-808. doi: 10.1113/EP088011. Epub 2020 Apr 22.

DOI:10.1113/EP088011
PMID:32086850
Abstract

NEW FINDINGS

What is the central question of this study? What is the role of lncRNA PRRT3-AS1 in the regulation of peroxisome proliferator-activated receptor γ (PPARγ) gene-mediated mechanistic target of rapamycin (mTOR) signalling pathway in proliferation, apoptosis and autophagy of prostate cancer cells? What is the main finding and its importance? The targeting relation between lncRNA PRRT3-AS1 and PPARγ was verified, and it was demonstrated that silencing of lncRNA PRRT3-AS1 can upregulate apoptosis and autophagy yet downregulate proliferation, migration and invasion of prostate cancer cells through the mTOR signalling pathway. Further work is needed to consolidate the therapeutic value of lncRNA PRRT3-AS1 in clinical trials and treatment of prostate cancer.

ABSTRACT

Although long non-coding RNAs (lncRNAs) are correlated with multiple cancers, their molecular mechanisms in prostate cancer (PC) remain inadequately understood. This study investigated the effects of lncRNA PRRT3-AS1 on the progression of prostate cancer (PC) with involvement of peroxisome proliferator-activated receptor γ (PPARγ). Microarray analysis was used to identify the differentially expressed genes and lncRNAs associated with PC. RT-qPCR and western blot analysis were employed to test the expression of lncRNA PRRT3-AS1, mammalian target of rapamycin (mTOR) signalling pathway-, apoptosis- and autophagy-related genes. A scratch test, Transwell assay, CCK-8 assay, colony formation assay, flow cytometry and monodansylcadaverine staining were employed to identify the migration, invasion, proliferation activity, cell cycle and apoptosis and autophagy of PC3 cells, respectively. Tumorigenicity assays in nude mice were used to detect the tumorigenic ability. GSE55945 and GSE46602 datasets indicated that lncRNA PRRT3-AS1 was highly expressed in PC. PPARγ was predicted as a target gene of lncRNA PRRT3-AS1. Ectopic overexpression of PPARγ or lncRNA PRRT3-AS1 silencing led to inhibited cell viability, migration and invasion, and accelerated apoptosis. Furthermore, the delivery of si-PRRT3-AS1 or PPARγ vector to PC3 cells resulted in the regression of xenografts in nude mice. Based on the in vitro and in vivo experiments, silencing of lncRNA PRRT3-AS1 was observed to activate the PPARγ gene, which in turn could inhibit PC cell proliferation and promote apoptosis and autophagy by blocking the mTOR signalling pathway.

摘要

新发现

本研究的核心问题是什么?长链非编码 RNA(lncRNA)PRRT3-AS1 在调节过氧化物酶体增殖物激活受体γ(PPARγ)基因介导的雷帕霉素(mTOR)信号通路对前列腺癌细胞增殖、凋亡和自噬的机制靶点中的作用是什么?主要发现及其重要性是什么?验证了 lncRNA PRRT3-AS1 与 PPARγ 的靶向关系,结果表明沉默 lncRNA PRRT3-AS1 可通过 mTOR 信号通路上调前列腺癌细胞的凋亡和自噬,而下调其增殖、迁移和侵袭。需要进一步的工作来巩固 lncRNA PRRT3-AS1 在临床试验和前列腺癌治疗中的治疗价值。

摘要

尽管长链非编码 RNA(lncRNA)与多种癌症相关,但它们在前列腺癌(PC)中的分子机制仍了解不足。本研究探讨了 lncRNA PRRT3-AS1 对过氧化物酶体增殖物激活受体γ(PPARγ)参与的前列腺癌(PC)进展的影响。采用微阵列分析鉴定与 PC 相关的差异表达基因和 lncRNA。RT-qPCR 和 Western blot 分析检测 lncRNA PRRT3-AS1、哺乳动物雷帕霉素靶蛋白(mTOR)信号通路、凋亡和自噬相关基因的表达。划痕试验、Transwell 试验、CCK-8 试验、集落形成试验、流式细胞术和单丹磺酰尸胺染色分别用于鉴定 PC3 细胞的迁移、侵袭、增殖活性、细胞周期和凋亡和自噬。裸鼠肿瘤生成实验用于检测致瘤能力。GSE55945 和 GSE46602 数据集表明 lncRNA PRRT3-AS1 在 PC 中高表达。预测 PPARγ 是 lncRNA PRRT3-AS1 的靶基因。过表达 PPARγ 或沉默 lncRNA PRRT3-AS1 可抑制细胞活力、迁移和侵袭,并加速凋亡。此外,向 PC3 细胞递送 si-PRRT3-AS1 或 PPARγ 载体可导致裸鼠异种移植物消退。基于体外和体内实验,沉默 lncRNA PRRT3-AS1 可激活 PPARγ 基因,进而通过阻断 mTOR 信号通路抑制 PC 细胞增殖并促进凋亡和自噬。

相似文献

1
Long non-coding RNA PRRT3-AS1 silencing inhibits prostate cancer cell proliferation and promotes apoptosis and autophagy.长链非编码 RNA PRRT3-AS1 沉默抑制前列腺癌细胞增殖并促进细胞凋亡和自噬。
Exp Physiol. 2020 May;105(5):793-808. doi: 10.1113/EP088011. Epub 2020 Apr 22.
2
LncRNA DCST1-AS1 accelerates the proliferation, metastasis and autophagy of hepatocellular carcinoma cell by AKT/mTOR signaling pathways.长链非编码 RNA DCST1-AS1 通过 AKT/mTOR 信号通路加速肝癌细胞的增殖、转移和自噬。
Eur Rev Med Pharmacol Sci. 2019 Jul;23(14):6091-6104. doi: 10.26355/eurrev_201907_18423.
3
Long non-coding RNA TNRC6C-AS1 promotes methylation of STK4 to inhibit thyroid carcinoma cell apoptosis and autophagy via Hippo signalling pathway.长链非编码 RNA TNRC6C-AS1 通过 Hippo 信号通路促进 STK4 的甲基化,从而抑制甲状腺癌细胞凋亡和自噬。
J Cell Mol Med. 2020 Jan;24(1):304-316. doi: 10.1111/jcmm.14728. Epub 2019 Oct 27.
4
LncRNA RHPN1-AS1 inhibition induces autophagy and apoptosis in prostate cancer cells via the miR-7-5p/EGFR/PI3K/AKT/mTOR signaling pathway.长链非编码 RNA RHPN1-AS1 通过 miR-7-5p/EGFR/PI3K/AKT/mTOR 信号通路抑制诱导前列腺癌细胞自噬和凋亡。
Environ Toxicol. 2022 Dec;37(12):3013-3027. doi: 10.1002/tox.23656. Epub 2022 Sep 20.
5
LncRNA LOXL1-AS1/miR-let-7a-5p/EGFR-related pathway regulates the doxorubicin resistance of prostate cancer DU-145 cells.LncRNA LOXL1-AS1/miR-let-7a-5p/EGFR 相关通路调控前列腺癌细胞 DU-145 对阿霉素的耐药性。
IUBMB Life. 2019 Oct;71(10):1537-1551. doi: 10.1002/iub.2075. Epub 2019 Jun 12.
6
Highly expressed long non-coding RNA FEZF1-AS1 promotes cells proliferation and metastasis through Notch signaling in prostate cancer.高表达的长链非编码RNA FEZF1-AS1通过Notch信号通路促进前列腺癌细胞的增殖和转移。
Eur Rev Med Pharmacol Sci. 2019 Jun;23(12):5122-5132. doi: 10.26355/eurrev_201906_18176.
7
The up-regulated lncRNA DLX6-AS1 in colorectal cancer promotes cell proliferation, invasion and migration via modulating PI3K/AKT/mTOR pathway.结直肠癌中上调的 lncRNA DLX6-AS1 通过调节 PI3K/AKT/mTOR 通路促进细胞增殖、侵袭和迁移。
Eur Rev Med Pharmacol Sci. 2019 Oct;23(19):8321-8331. doi: 10.26355/eurrev_201910_19143.
8
Silencing of long noncoding RNA HOXD-AS1 inhibits proliferation, cell cycle progression, migration and invasion of hepatocellular carcinoma cells through MEK/ERK pathway.长链非编码 RNA HOXD-AS1 的沉默通过 MEK/ERK 通路抑制肝癌细胞的增殖、细胞周期进程、迁移和侵袭。
J Cell Biochem. 2020 Jan;121(1):443-457. doi: 10.1002/jcb.29206. Epub 2019 Jun 23.
9
Downregulation of lncRNA ZEB1-AS1 Represses Cell Proliferation, Migration, and Invasion Through Mediating PI3K/AKT/mTOR Signaling by miR-342-3p/CUL4B Axis in Prostate Cancer.长链非编码 RNA ZEB1-AS1 下调通过 miR-342-3p/CUL4B 轴调控 PI3K/AKT/mTOR 信号通路抑制前列腺癌细胞增殖、迁移和侵袭。
Cancer Biother Radiopharm. 2020 Nov;35(9):661-672. doi: 10.1089/cbr.2019.3123. Epub 2020 Apr 9.
10
RREB1-induced upregulation of the lncRNA AGAP2-AS1 regulates the proliferation and migration of pancreatic cancer partly through suppressing ANKRD1 and ANGPTL4.RREB1 诱导的 lncRNA AGAP2-AS1 上调部分通过抑制 ANKRD1 和 ANGPTL4 调节胰腺癌的增殖和迁移。
Cell Death Dis. 2019 Feb 27;10(3):207. doi: 10.1038/s41419-019-1384-9.

引用本文的文献

1
Regulating the regulators: long non-coding RNAs as autophagic controllers in chronic disease management.调控调控因子:长链非编码RNA作为慢性疾病管理中的自噬调控因子
J Biomed Sci. 2024 Dec 23;31(1):105. doi: 10.1186/s12929-024-01092-9.
2
Long noncoding RNA mediates enzalutamide resistance and transformation in neuroendocrine prostate cancer.长链非编码RNA介导神经内分泌前列腺癌中的恩杂鲁胺耐药性及转化。
Front Oncol. 2024 Nov 25;14:1481777. doi: 10.3389/fonc.2024.1481777. eCollection 2024.
3
Critical roles of lncRNA-mediated autophagy in urologic malignancies.
长链非编码RNA介导的自噬在泌尿系统恶性肿瘤中的关键作用
Front Pharmacol. 2024 Jun 13;15:1405199. doi: 10.3389/fphar.2024.1405199. eCollection 2024.
4
Comprehensive data mining reveals RTK/RAS signaling pathway as a promoter of prostate cancer lineage plasticity through transcription factors and CNV.全面的数据挖掘揭示了 RTK/RAS 信号通路通过转录因子和 CNV 促进前列腺癌谱系可塑性。
Sci Rep. 2024 May 22;14(1):11688. doi: 10.1038/s41598-024-62256-z.
5
An update on methods for detection of prognostic and predictive biomarkers in melanoma.黑色素瘤预后和预测生物标志物检测方法的最新进展。
Front Cell Dev Biol. 2023 Oct 13;11:1290696. doi: 10.3389/fcell.2023.1290696. eCollection 2023.
6
Autophagy, a critical element in the aging male reproductive disorders and prostate cancer: a therapeutic point of view.自噬,男性生殖功能障碍和前列腺癌老化的关键因素:治疗观点。
Reprod Biol Endocrinol. 2023 Sep 26;21(1):88. doi: 10.1186/s12958-023-01134-1.
7
Autophagy-related lncRNAs in tumor progression and drug resistance: A double-edged sword.肿瘤进展和耐药性中与自噬相关的长链非编码RNA:一把双刃剑
Genes Dis. 2023 Jun 16;11(1):367-381. doi: 10.1016/j.gendis.2023.04.015. eCollection 2024 Jan.
8
LncRNA PRRT3-AS1 exerts oncogenic effects on nonsmall cell lung cancer by targeting microRNA-507/homeobox B5 axis.长链非编码 RNA PRRT3-AS1 通过靶向 microRNA-507/同源盒 B5 轴对非小细胞肺癌发挥致癌作用。
Oncol Res. 2022 Nov 10;29(6):411-423. doi: 10.32604/or.2022.026236. eCollection 2021.
9
Importance of long non-coding RNAs in the pathogenesis, diagnosis, and treatment of prostate cancer.长链非编码RNA在前列腺癌发病机制、诊断及治疗中的重要性。
Front Oncol. 2023 Mar 21;13:1123101. doi: 10.3389/fonc.2023.1123101. eCollection 2023.
10
Targeting Autophagy Using Long Non-Coding RNAs (LncRNAs): New Landscapes in the Arena of Cancer Therapeutics.靶向自噬作用的长链非编码 RNA(lncRNAs):癌症治疗领域的新领域。
Cells. 2023 Mar 6;12(5):810. doi: 10.3390/cells12050810.